NCT02885974

Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

CompletedPHASE1INTERVENTIONAL

Trial Details

Start: 2016-12Est. Completion: 2024-03

Enrollment target: 22 participants

Locations

Baylor Clinic, Houston, Texas, United States
Harris Health System - Smith Clinic, Houston, Texas, United States

Other microbiome trials you might be interested in

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsPhase 1Recruiting

Breast CancerSmall Cell Lung CancerOvarian CancerGastric CancerHormone-receptor-positive Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerAdvanced Solid TumorEndometrial CancerProstate CancerTNBC - Triple-Negative Breast CancerGastroEsophageal CancerBladder Cancer

This study is a first-in-human (FIH), Phase 1a/1b study of BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), to a…

Newport Beach, United StatesEst. completion Aug 31, 2026

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.